Xtandi

Astellas in ‘unacceptable’ Xtandi ABPI code breach

July 3, 2015
Medical Communications, Sales and Marketing ABPI Code, Astella, PMCPA, Xtandi

The industry code of conduct regulator has singled out Astellas for ‘particular censure’ for arranging a meeting for UK healthcare …

Prices to be printed on all prescribed NHS drugs over £20

July 2, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing Jeremy Hunt, NHS, UK, drugs, health secretary, medicines

NHS drugs costing more than £20 will, from next year, have the price and the words “funded by the UK …

BI building

Boehringer Ingelheim launches Spiolto for COPD

July 2, 2015
Sales and Marketing Boehringer Ingelheim, COPD, Europe, Spiolto, Spiriva, Striverdi

Boehringer Ingelheim is beginning a new push in lung disease across Europe after being approved by regulators in nine countries …

Drug R&D

Pharma outsourcing: CROs, CMOs and external collaboration

July 2, 2015
Manufacturing and Production, Research and Development CMOs, R&D, clinical trials, collaboration, cros, outsourcing

Thirty years ago pharma companies seemed to use external contractors as a sort of fire brigade, to be called in …

dr_goddard

Mission Therapeutics appoints Dr Colin Goddard to its board of directors

July 2, 2015
Research and Development Colin Goddard, Mission Therapeutics, appointments

MISSION Therapeutics, a drug discovery and development company today has appointed Dr Colin Goddard, former chief executive of OSI Pharmaceuticals, …

Opdivo launched in the UK for skin cancer

July 2, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, EMA, Early Access to Medicines Scheme, MHRA, eams, melanoma, opdivo, skin cancer

Bristol-Myers Squibb has launched its cancer immunotherapy treatment Opdivo in the UK for patients with advanced skin cancer. Opdivo (nivolumab) …

michael_le_brocq

DJM Unlimited makes new director appointment

July 1, 2015
Medical Communications DJM Unlimited, Michael Le Brocq

UK and US based company DJM Unlimited has appointed Michael Le Brocq as board director. Le Brocq has 20 years’ …

Professor Dame Sally Davies

Pfizer partners with NIHR to boosts UK R&D

July 1, 2015
Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies

Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …

Novartis launches ViaOpta Apple Watch app

July 1, 2015
Medical Communications Novartis, apple watch, apps, visual impairment, wearables

Novartis has launched new features of its ViaOpta app for use with the Apple Watch and other wearable devices. The …

Boehringer and Vitae Pharma drug fails in mid-stage trial

July 1, 2015
Research and Development BI, Boehringer, Boehringer Ingelheim, Vitae Pharmaceuticals, diabetes, type 2 diabetes

A pipeline diabetes drug co-developed by Vitae Pharma and German giants Boehringer Ingelheim has failed to show benefits in a …

FDA image

FDA sued over failure to disclose Sovaldi data

June 30, 2015
Sales and Marketing FDA, Gilead, hepatitis C, sofosbuvir, sovaldi

Two groups that campaign for wider access to medicines have filed a lawsuit against the FDA, in a bid to …

image

Celgene enters 10-year $1 billion pact with Juno

June 30, 2015
Research and Development, Sales and Marketing CAR-T, Celgene, Chimeric Antigen Receptor Technology, Juno, T Cell Receptor, TCR, brett wells

Celgene has invested $1 billion into Juno Therapeutics as part of a 10-year partnership aiming to study cures for cancer …

BMS’ Opdivo accepted to UK early access scheme

June 30, 2015
Sales and Marketing BMS, Cancer, NSCLC, eams, keytruda, opdivo

Bristol-Myers Squibb has scored another first with its new-generation oncology therapy Opdivo, which has become the first lung cancer drug …

peter_henshaw

The Partners hires creative director from InVentive

June 30, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Novo Nordisk, The International Aids Society, The partners, inventive, peter henshaw

Brand consultancy The Partners has appointed creative director Peter Henshaw to lead its creative offerings for the agency’s health team.  …

Lilly image

Lilly and Immunocore collaborate on melanoma

June 29, 2015
Research and Development, Sales and Marketing LY2157299, LY2801653, brett wells, immunocore, lilly

Eli Lilly is teaming up again with UK biotech Immunocore in order to work together on immunotherapy-based clinical trials. Specifically …

Boehringer image

Boehringer scores trial success for Pradaxa antidote

June 29, 2015
Research and Development, Sales and Marketing Boehringer, Pradaxa, idarucizumab

Bosses at Boehringer Ingelheim say the latest results of a study of idarucizumab, and antidote for its blockbuster blood-thinner Pradaxa, …

Novartis spends $200m on pain firm Spinifex

June 29, 2015
Sales and Marketing Cosentyx, EMA401, Novartis, Secukinumab, spinifex

Novartis is spending $200 million to increase its presence in pain management through the purchase of US-Australian biotech Spinifex Pharmaceuticals.  …

Bayer image

Bayer’s Eylea approved in Japan

June 29, 2015
Sales and Marketing Eylea, Japan, aflibercept. bayer

German firm Bayer has been shown the green light by the Japanese Ministry of Health, Labour and Welfare to market …

charles_woler

Synexus announces new board

June 29, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synexus, woler

Following a management buyout Synexus has confirmed who its new board members are to steer the UK recruitment and clinical …

The Gateway to Local Adoption Series

Latest content